Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark · Delayed Price · Currency is DKK 2.810
-0.050 (-1.75%)
May 27, 2026, 4:42 PM CET
CPH:SMSMED Revenue
Scandinavian Medical Solutions had revenue of 122.69M DKK in the half year ending September 30, 2025, with 29.22% growth. This brings the company's revenue in the last twelve months to 214.99M, down -12.91% year-over-year. In the fiscal year ending September 30, 2025, Scandinavian Medical Solutions had annual revenue of 245.44M with 8.28% growth.
Revenue (ttm)
214.99M
Revenue Growth
-12.91%
P/S Ratio
0.37
Revenue / Employee
7.41M
Employees
29
Market Cap
79.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 245.44M | 18.76M | 8.28% |
| Sep 30, 2024 | 226.68M | 35.49M | 18.56% |
| Sep 30, 2023 | 191.19M | 80.66M | 72.98% |
| Sep 30, 2022 | 110.53M | 38.89M | 54.29% |
| Sep 30, 2021 | 71.64M | 29.69M | 70.78% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| Genmab | 25.29B |
| ALK-Abelló | 6.56B |
| Gubra | 2.64B |
| BioPorto | 40.29M |
| Stenocare | 9.24M |
| ViroGates | 9.01M |
Scandinavian Medical Solutions News
- 7 days ago - Scandinavian Medical Solutions Quarterly report: H1 2026 - Filings
- 6 months ago - Scandinavian Medical Solutions Annual report: H2 2025 - Filings